Eastern Cooperative Oncology Group
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2012-01-01
- Employees
- 51
- Market Cap
- -
- Website
- https://ecog-acrin.org
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
- Conditions
- First Posted Date
- 2012-07-31
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 400
- Registration Number
- NCT01653613
Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial
Completed
- Conditions
- First Posted Date
- 2012-06-14
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 183
- Registration Number
- NCT01619618
Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia
Completed
- Conditions
- First Posted Date
- 2012-01-06
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 186
- Registration Number
- NCT01505699
Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim
Completed
- Conditions
- First Posted Date
- 2011-12-09
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 270
- Registration Number
- NCT01489423
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
Completed
- Conditions
- First Posted Date
- 2011-12-07
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 155
- Registration Number
- NCT01487733
Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397
Completed
- Conditions
- First Posted Date
- 2011-11-06
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 42
- Registration Number
- NCT01466244
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia
Completed
- Conditions
- First Posted Date
- 2011-08-23
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 257
- Registration Number
- NCT01421875
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2011-08-12
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 373
- Registration Number
- NCT01415752
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸Mount Sinai Hospital Medical Center, Chicago, Illinois, United States
DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402
Completed
- Conditions
- First Posted Date
- 2011-08-01
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 200
- Registration Number
- NCT01406782
Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms
Completed
- Conditions
- First Posted Date
- 2011-07-11
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 32
- Registration Number
- NCT01390597
© Copyright 2024. All Rights Reserved by MedPath